Advertisement

Topics

Wellnext expands portfolio of brands with NeoCell

02:03 EDT 8 Aug 2017 | PR Newswire

SUNRISE, Fla., Aug. 8, 2017 /PRNewswire/ -- Wellnext LLC (http://www.wellnexthealth.com), a vertically-integrated developer, manufacturer, and marketer of dietary and nutritional supplements, announces the acquisition of NeoCell, a leading collagen supplement company, based in Irvine, California.

For nearly two decades, NeoCell has specialized in collagen-based supplements for joint, bone, and muscle health using advanced formulas based on high quality ingredients such as collagen, biotin and hyaluronic acid. NeoCell is a leading collagen-brand across natural as well as traditional retailers nationwide.

"We are very excited to partner with Wellnext and gain the support of its operational and commercial capabilities to further expand NeoCell," said Sarah Quadri, NeoCell's Chief Operating Officer. "We are confident that Wellnext will provide unique manufacturing, product development, and market expansion capabilities to support NeoCell's next phase of growth."

NeoCell represents the fourth acquisition made by Wellnext in the last two years. "NeoCell complements Wellnext's portfolio of brands, expanding it into the fast-growing collagen category while diversifying the company's product category focus," Jose Minski, CEO of Wellnext, states. "We are excited to work with NeoCell's industry-leading products for beauty, bone and joint health."

Wellnext is a portfolio company owned by an affiliate of WM Partners, LP. WM Partners is a Ft. Lauderdale-based private equity firm focused on investing in middle-market companies in the health and wellness sector.

PNC Business Credit, a division of PNC Bank, N.A., and McLarty Capital Partners were the lead funding agents. Pepper Hamilton LLP served as Wellnext's legal advisor on the transaction.

About NeoCell Based in Irvine, California, NeoCell is a leading collagen supplement brand in the US. Since its founding by Al Quadri in 1998, NeoCell has focused on supporting the body's collagen systems, such as those that maintain vibrant youth, radiant beauty, and total body wellness. Over the years, the brand has become a leading consumer source for NeoCell® Super Collagen™ Type 1 & 3, NeoCell® Super Collagen+C, NeoCell Beauty Bursts® Gourmet Collagen Chews, NeoCell® Collagen+C™ Pomegranate Liquid, and NeoCell Hyaluronic Acid Blueberry Liquid. For additional information, visit https://www.neocell.com.

About Wellnext Headquartered in Sunrise, Florida, the Wellnext family of brands delivers research-backed nutritional supplements for every consumer life stage. Anchor brands within the Wellnext portfolio include a GMP-certified manufacturer with 30 years of leadership in supplement manufacturing, Rainbow Light®, Champion Performance®, and Natural Vitality®, among many other leading brands. Guided by three generations of family heritage, Wellnext is committed to the highest standards of corporate social responsibility, including product quality and purity testing, sustainability practices, and corporate giving programs, to help foster a vibrant state of health in families everywhere. For more information, visit http://www.wellnexthealth.com. Wellnext is not affiliated or related to Wellnx Life Sciences, Inc.

About WM Partners, LP WM Partners is a middle-market private equity firm specialized in buyout investments in the health and wellness sectors. WM Partners seeks to acquire small and medium size businesses with attractive growth prospects and generate sustainable, long-term value through its operational expertise in the health and wellness sectors, and strategic business approach working in collaboration with experienced management teams. WM Partners is based in Ft. Lauderdale, FL. More information about WM Partners is available at www.wmplp.com.

View original content:http://www.prnewswire.com/news-releases/wellnext-expands-portfolio-of-brands-with-neocell-300500917.html

SOURCE Wellnext LLC

NEXT ARTICLE

More From BioPortfolio on "Wellnext expands portfolio of brands with NeoCell"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...